Search details
1.
Isoformic PD-1-mediated immunosuppression underlies resistance to PD-1 blockade in hepatocellular carcinoma patients.
Gut
; 72(8): 1568-1580, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-36450387
2.
Enhancing the efficacy of vaccinia-based oncolytic virotherapy by inhibiting CXCR2-mediated MDSC trafficking.
J Leukoc Biol
; 115(4): 633-646, 2024 Mar 29.
Article
in English
| MEDLINE | ID: mdl-38066571
3.
Eliminating mesothelioma by AAV-vectored, PD1-based vaccination in the tumor microenvironment.
Mol Ther Oncolytics
; 20: 373-386, 2021 Mar 26.
Article
in English
| MEDLINE | ID: mdl-33614918
4.
Antimesothelioma Immunotherapy by CTLA-4 Blockade Depends on Active PD1-Based TWIST1 Vaccination.
Mol Ther Oncolytics
; 16: 302-317, 2020 Mar 27.
Article
in English
| MEDLINE | ID: mdl-32195318
5.
Virotherapy-recruited PMN-MDSC infiltration of mesothelioma blocks antitumor CTL by IL-10-mediated dendritic cell suppression.
Oncoimmunology
; 8(1): e1518672, 2019.
Article
in English
| MEDLINE | ID: mdl-30546960
Results
1 -
5
de 5
1
Next >
>>